OncoSec Medical Inc. announced it has entered into a collaboration with Dana-Farber Cancer Institute, and The Marasco Laboratory, led by Wayne Marasco, to develop CAR-T cell therapies for triple-negative breast cancer and other solid tumors.
To access this subscriber-only content please log in or renew your subscription.
Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.
Login Subscribe
Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.
Login Subscribe